Cancer Care Referral Program

1.Comprehensive Diagnostics with Imaging

• Real-time Imaging – upon arrival, patient undergoes whole-body PET/CT (CT scan cannot detect potential metastatic cancer at the crucial molecular level) complete physical examination, lab/blood work, initial consultation, and more.)
• Multi-platform diagnostics – real-time imaging via PET/CT, MRI, etc., and where indicated, Live-Cell Tumor Profiling (laboratory technique to measure how cancer cells respond to a variety of drugs and drug combinations) or Liquid Biopsy ala NGS genomics, transcriptomics.
• Metabolic Profiling – via state-of-the-art Quantitative Mass Spectrometer.
• Tumor Board Review by our Multiple Medical Oncology Team and Specialists for Treatment Strategy (initiate cutting-edge cancer treatment protocols that apply biomarker-driven, and in-depth interrogation of tumor biology to craft unique patient-specific treatment regimens ala initial Total Neoadjuvant Therapy followed with complete post Adjuvant therapeutics and more).

2.Next-Generation Total Neoadjuvant Therapeutics 

• Low-dose Radiation with Synergistic Cytostatic Agent (CCRT) and CoNexus Intratumoral Immunotherapy – a cancer treatment that uses high doses of radiation to kill cancer cells and shrink tumors. Chemo-sensitizing agents (aka radiosensitizers) are chemicals or pharmaceutical agents that enhance the killing effect on tumor cells by accelerating DNA damage and producing free radicals indirectly – having little effect on normal tissues. Over the last twenty years,  physicians have developed treatment strategies that exploit the development of radiosensitizers becoming highly effective yet with low toxicity, e.g. small molecules, macromolecules, and nanomaterials.
• CoNexus Intratumoral Immunotherapy – uses the tumor as its vaccine by generating antitumor immunity against cancer cell antigens. It allows being agnostic from the nature of the most immunogenic cancer cell antigens while enabling the generation of a polyclonal antitumor immune response against multiple cancer targets which provides a better opportunity to address the heterogeneity of the disease. The abscopal effect occurs when radiation treatment together with intratumoral immunotherapy not only shrinks the targeted tumor(s) but leads to shrinkage of possible untreated tumors elsewhere in the body.
• Allogenic Natural Killer cells (NK cells) – the first line of the innate immune defense system, primarily located in peripheral circulation and lymphoid tissues; destroy virally infected/malignant cells through a balancing play of inhibitory and stimulatory receptors. NK cells show anti-tumor effects and are used in the adoptive transfer of activated and expanded cells, ex-vivo. NK cells express co-stimulatory molecules that are attractive targets for the immunotherapy of cancers.
• Hyperthermia Treatment – is indeed a treatment method where body tissue is heated to high temperatures to target and destroy cancer cells while minimizing harm to normal tissue. This approach, also known as thermal therapy or thermotherapy, is often used in conjunction with other cancer treatments like radiation therapy and chemotherapy for advanced cases. Clinical studies have demonstrated that combining hyperthermia with these treatments can help reduce tumor size and enhance the effectiveness of killing cancer cells. It’s important to consult healthcare professionals to determine the best treatment plan for individual cases.

3. Thermal Tumor Ablation

• A safe and effective treatment option for destructing tumors without surgery for body disfigurement, or has multiple tumors in the lungs, bones, or liver that have spread from primary cancer elsewhere in the body, such as the kidney, intestine, or breast (metastasis.)

4. Regenerative and Restorative Medicine

• Replace, restore, or revitalize cellular tissues or organs, which have been compromised and/or damaged by disease, trauma, or congenital symptoms.